BF
ESPR icon

BOK Financial’s Esperion Therapeutics ESPR Stock Holding History

BOK Financial’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.5K Buy
32,298
+8,275
+34% +$26.2K ﹤0.01% 763
2025
Q4 		$88.9K Hold
24,023
– – ﹤0.01% 776
2025
Q3 		$63.7K Buy
24,023
+12,118
+102% +$23.4K ﹤0.01% 816
2025
Q2 		$11.7K Hold
11,905
– – ﹤0.01% 957
2025
Q1 		$17.1K Hold
11,905
– – ﹤0.01% 934
2024
Q4 		$27.9K Hold
11,905
– – ﹤0.01% 883
2024
Q3 		$23.3K Hold
11,905
– – ﹤0.01% 908
2024
Q2 		$26.4K Buy
+11,905
New +$28K ﹤0.01% 906
2019
Q1 		– Sell
-6,168
Closed -$284K – 915
2018
Q4 		$284K Sell
6,168
-2,892
-32% -$139K 0.01% 747
2018
Q3 		$401K Buy
+9,060
New +$416K 0.01% 727

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return